1e
19
1
49
2
2
18
1b
1d
18
4a
9c
1d
2 29
1d
25
Charles E. Leonard, PharmD, MSCE, MPH, FISPE
78
9c
Associate Professor of Epidemiology in Biostatistics and Epidemiology at the Hospital of the University of Pennsylvania
28
ba
3
75
Investigator, Center for Real-World Effectiveness and Safety of Therapeutics (CREST, formerly CPeRT), DBEI, PSOM (Philadelphia, PA)
9d
Faculty Member, Institute for Translational Medicine and Therapeutics (ITMAT), PSOM (Philadelphia, PA)
a6
Senior Fellow, Leonard Davis Institute of Health Economics (LDI), University of Pennsylvania (Philadelphia, PA)
80
Fellow, Institute on Aging, University of Pennsylvania (Philadelphia, PA)
64
Senior Scholar, CCEB, PSOM (Philadelphia, PA)
7e
Co-Chair, Training Program Working Group, CCEB, PSOM (Philadelphia, PA)
95
Investigator, Center of Excellence in Environmental Toxicology (CEET), PSOM (Philadelphia, PA)
11
Department: Biostatistics and Epidemiology
4
1
23
1f
Graduate Group Affiliations
8
a
b
1d
46
Contact information
6b
4
3
3
3
2
29
6b
Perelman School of Medicine at the University of Pennsylvania
16 Floor 4W, 105D
3a 3600 Civic Center Blvd.
Philadelphia, PA 19104
26
16 Floor 4W, 105D
3a 3600 Civic Center Blvd.
Philadelphia, PA 19104
2e
Office: 215-573-2663
3e Lab: 215-573-2663
18
9f
12
3e Lab: 215-573-2663
18
Links
89 UPenn DBEI Faculty Page
73 ResearchGate Profile
5b Wikidata
81 Google Scholar Profile
8f UPenn CCEB Senior Scholar Page
66 LinkedIn Profile
7f UPenn PSOM Faculty Page
7b UPenn LDI Faculty Page
c
4
b
1f
89 UPenn DBEI Faculty Page
73 ResearchGate Profile
5b Wikidata
81 Google Scholar Profile
8f UPenn CCEB Senior Scholar Page
66 LinkedIn Profile
7f UPenn PSOM Faculty Page
7b UPenn LDI Faculty Page
c
13
Education:
21 b PharmD 1e (Clinical Pharmacy) c
2c Duquesne University, 2001.
21 9 MSCE 22 (Clinical Epidemiology) c
33 University of Pennsylvania, 2011.
21 8 MPH 1a (Public Health) c
28 Yale University, 2025.
c
3
3
3
3
8c
Permanent link21 b PharmD 1e (Clinical Pharmacy) c
2c Duquesne University, 2001.
21 9 MSCE 22 (Clinical Epidemiology) c
33 University of Pennsylvania, 2011.
21 8 MPH 1a (Public Health) c
28 Yale University, 2025.
c
2 29
21
1e
1d
24
5e
71
e 29
27
Description of Clinical Expertise
18 pharmacy71
Description of Research Expertise
1c2 epidemiology, pharmacoepidemiology, real-world evidence, comparative effectiveness, comparative safety, observational studies, cohort, case-control, self-controlled case series, case-crossover, pharmacovigilance, Medicaid, Medicare, drug interactions, sudden cardiac arrest, ventricular arrhythmia, diabetes, hypoglycemia, diabetic ketoacidosis, ischemic stroke, propensity scores, high-dimensional propensity scores, causal inferencee 29
23
114 Nock MR, Ahn S, Leonard CE, Ogdie A, Cohen JM: Ambient temperature and psoriatic arthritis odds among patients with psoriasis: A cross-sectional analysis. J Psoriasis Psoriatic Arthritis [in press] 2026.
167 Harris DA, D'Amico A, Mehta HB, Daiello LA, Berry SD, Leonard CE, Hsu YC, Kiel D, Hayes KN, Riester M, Roberts JE, Reich L, Free P, Zullo AR: Identifying observable medication use time in administrative databases: A tutorial using nursing home residents. Am J Epidemiol [in press] 2025.
159 Pham Nguyen TP, Leonard CE, Brensinger CM, Bilker WB, Chung SP, Horn JR, Bogar K, Miano TA, Hennessy S: Effect of concomitant use of oral anticoagulants and oral dipeptidyl peptidase-4 inhibitors on serious bleeding events. Clin Pharmacol Ther 117(4): 1012-1016, Apr 2025.
1a5 Leonard CE, Bogar K, Brensinger CM, Bilker WB, Bell ML, Flory JH, Shi C, Chen C, Hennessy S.: Do relationships between ambient temperature and serious adverse health outcomes vary among users of different antidiabetes drugs? A retrospective cohort study of United States Medicaid beneficiaries with type 2 diabetes. BMJ Open 14: e085139, Oct 2024 Notes: doi:10.1136/ 28 bmjopen-2024-085139.
151 Dhopeshwarkar N, Yang W, Hennessy S, Rhodes JM, Cuker A, Leonard CE: SuperLearner with high-dimensional propensity score to improve confounding adjustment: A real-world application in chronic lymphocytic leukemia. Pharmacoepidemiol Drug Saf 33(1): e5678, Jan 2024.
11a Dhopeshwarkar N, Yang W, Hennessy S, Rhodes JM, Cuker A, Leonard CE.: Bleeding with concomitant ibrutinib and oral anticoagulant therapy: A population-based cohort study. Am J Hematol 98(3): E49-E52, Mar 2023.
11b Dawwas GK, Leonard CE, Lewis JD, Cuker A.: Risk for Recurrent Venous Thromboembolism and Bleeding With Apixaban Compared With Rivaroxaban: An Analysis of Real-World Data. Ann Intern Med 175(1): 20-28, Jan 2022.
d7 Medaglio D, Stephens-Shields AJ, Leonard CE.: Research and scholarly methods: Propensity scores. J Am Coll Clin Pharm 5(4): 467-475, Apr 2022.
18a Bogar K, Brensinger CM, Hennessy S, Flory JH, Bell ML, Shi C, Bilker WB, Leonard CE.: Climate change and ambient temperature extremes: Association with serious hypoglycemia, diabetic ketoacidosis, and sudden cardiac arrest/ventricular arrhythmia in persons with type 2 diabetes. Diabetes Care 45(11): e171-e173, Nov 2022.
2c
7
1d
1f
Selected Publications
14b Pham Nguyen TP, Hennessy S, Brensinger CM, Bilker WB, Dember LM, Miano TA, Vo T, Willis AW, Leonard CE: Impact of empiric potassium supplementation on mortality, sudden cardiac arrest, and stroke in furosemide initiators. Br J Clin Pharmacol [in press] 2026.114 Nock MR, Ahn S, Leonard CE, Ogdie A, Cohen JM: Ambient temperature and psoriatic arthritis odds among patients with psoriasis: A cross-sectional analysis. J Psoriasis Psoriatic Arthritis [in press] 2026.
167 Harris DA, D'Amico A, Mehta HB, Daiello LA, Berry SD, Leonard CE, Hsu YC, Kiel D, Hayes KN, Riester M, Roberts JE, Reich L, Free P, Zullo AR: Identifying observable medication use time in administrative databases: A tutorial using nursing home residents. Am J Epidemiol [in press] 2025.
159 Pham Nguyen TP, Leonard CE, Brensinger CM, Bilker WB, Chung SP, Horn JR, Bogar K, Miano TA, Hennessy S: Effect of concomitant use of oral anticoagulants and oral dipeptidyl peptidase-4 inhibitors on serious bleeding events. Clin Pharmacol Ther 117(4): 1012-1016, Apr 2025.
1a5 Leonard CE, Bogar K, Brensinger CM, Bilker WB, Bell ML, Flory JH, Shi C, Chen C, Hennessy S.: Do relationships between ambient temperature and serious adverse health outcomes vary among users of different antidiabetes drugs? A retrospective cohort study of United States Medicaid beneficiaries with type 2 diabetes. BMJ Open 14: e085139, Oct 2024 Notes: doi:10.1136/ 28 bmjopen-2024-085139.
151 Dhopeshwarkar N, Yang W, Hennessy S, Rhodes JM, Cuker A, Leonard CE: SuperLearner with high-dimensional propensity score to improve confounding adjustment: A real-world application in chronic lymphocytic leukemia. Pharmacoepidemiol Drug Saf 33(1): e5678, Jan 2024.
11a Dhopeshwarkar N, Yang W, Hennessy S, Rhodes JM, Cuker A, Leonard CE.: Bleeding with concomitant ibrutinib and oral anticoagulant therapy: A population-based cohort study. Am J Hematol 98(3): E49-E52, Mar 2023.
11b Dawwas GK, Leonard CE, Lewis JD, Cuker A.: Risk for Recurrent Venous Thromboembolism and Bleeding With Apixaban Compared With Rivaroxaban: An Analysis of Real-World Data. Ann Intern Med 175(1): 20-28, Jan 2022.
d7 Medaglio D, Stephens-Shields AJ, Leonard CE.: Research and scholarly methods: Propensity scores. J Am Coll Clin Pharm 5(4): 467-475, Apr 2022.
18a Bogar K, Brensinger CM, Hennessy S, Flory JH, Bell ML, Shi C, Bilker WB, Leonard CE.: Climate change and ambient temperature extremes: Association with serious hypoglycemia, diabetic ketoacidosis, and sudden cardiac arrest/ventricular arrhythmia in persons with type 2 diabetes. Diabetes Care 45(11): e171-e173, Nov 2022.
2c